fashion -WSS

fashion

author：knowledge 2025-10-01 07:41:12 - browse：53126

Daphne Koller -- biotech coverage from STAT — Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

But what exactly is Koller building?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： VC firm General Catalyst wants to buy a health system

WSS

Histogen: Failed biotech offers rare public look inside

Why Charlie Gard's case is so disturbing to Americans

Why age limits for politicians are a terrible idea

HHS secretary Becerra pressed on Change HealthCare cyberattack

VC firm General Catalyst wants to buy a health system

Physician executives need more than on

entertainment

fashion

focus

Anesthesiologist group: stop taking Ozempic before surgery

Bristol 'take

Medicare details structure of new drug price negotiation program

EPA limits use of carcinogenic gas for sterilizing medical devices

What does generative AI mean for health care? We asked experts

When women are denied an abortion, their children fare worse than peers

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

UCLA team creates talking throat patch for voice disorders

Medicare details structure of new drug price negotiation program

Liquid biopsy for lung cancer is launched by Delfi

leisure time

President Biden's budget: Here's what you might have missed

Phenylephrine and the overlooked value of the placebo effect

Chemotherapy drug shortage eases slightly but still widespread

WuXi out of biotech trade group, U.S. and China relations to blame

HHS secretary Becerra pressed on Change HealthCare cyberattack

Readout Newsletter: CAR

Wikipedia

focus

explore

Wikipedia